March 17, 2025 08:50 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Union minister Aswini Vaishnaw calls Tamil a ‘sweet language’ amid Tamil Nadu’s Hindi imposition row | Bengal's Birbhum witnesses violent clashes over Holi; internet suspended, heavy security deployed | Haryana BJP leader shot dead by neighbour over land dispute, incident caught on camera | Airbag blocked my view, claims 20-year-old law student whose car crashed into vehicles killing 1 in Vadodara | Mark Carney takes oath as new Canada Prime Minister | Man attacks people with iron rod inside Golden Temple in Amritsar, leaves 5 injured | Not disrespectful: Tamilian who designed rupee symbol reacts to Stalin govt's currency move | In a setback for Donald Trump, US judge orders federal agencies to rehire fired workers: Report | 'We will thwart conspiracies hatched by Centre': Revanth Reddy on delimitation exercise | Chennai doctor, his wife along with two sons die by suicide due to huge debt: Cops
India gets its first covid nasal vaccine iNCOVACC manufactured by Bharat Biotech

India gets its first covid nasal vaccine iNCOVACC manufactured by Bharat Biotech

Jan 26, 2023, at 10:11 pm

New Delhi/IBNS: Union Health Minister Dr Mansukh Mandaviya and Science and Technology Minister Jitendra Singh Thursday launched the world's first COVID-19 intranasal vaccine, iNCOVACC.

Govt approved Bharat Biotech's nasal anti-Covid vaccine: Reports

Govt approved Bharat Biotech's nasal anti-Covid vaccine: Reports

Dec 23, 2022, at 05:24 pm

New Delhi/IBNS/UNI: The central government has approved Bharat Biotech's nasal vaccine against Covid-19 amid the fresh scare of a surge in infections, media reports said.

Bharat Biotech's 1st nasal COVID vaccine gets approval for phase 2 trial

Bharat Biotech's 1st nasal COVID vaccine gets approval for phase 2 trial

Aug 14, 2021, at 02:49 am

New Delhi/IBNS: Bharat Biotech has received phase 2 human clinical trial nod for its nasal COVID vaccine, called BBV154, the Union Government informed on Friday.

Nasal vaccine against COVID-19 prevents infection in mice: Study

Nasal vaccine against COVID-19 prevents infection in mice: Study

Aug 23, 2020, at 03:19 am

Washignton: Scientists at Washington University School of Medicine in St. Louis have developed a vaccine that targets the SARS-CoV-2 virus, can be given in one dose via the nose and is effective in preventing infection in mice susceptible to the novel coronavirus. 

Close menu